Allulose, 1-kestose, and resistant maltodextrin differentially modulate postprandial glucose, GLP-1, and satiety in humans
Background
Effective postprandial glycemic regulation is crucial for preventing chronic metabolic conditions like Type 2 Diabetes. While pharmacological interventions, such as GLP-1 receptor agonists, offer robust control, they often come with side effects or require injections. Dietary strategies utilizing low-digestible carbohydrates (LDCs) present a promising, sustainable, and complementary approach to manage glucose homeostasis and insulin sensitivity. This research explores how specific LDCs can uniquely influence incretin hormone release and satiety signals, addressing a gap in understanding their distinct physiological impacts.
Study Design
Two human physiological investigations evaluated the acute metabolic responses to specific LDCs. Study 1 assessed allulose, 1-kestose, resistant maltodextrin (RD), and fructo-oligosaccharide powder (FOP) when consumed in isolation. Study 2 examined these LDCs in conjunction with a reference meal (RM). Primary endpoints included plasma glucose, insulin, and GLP-1 concentrations, alongside subjective satiety ratings. Participants consumed specific doses of each LDC, with metabolic responses tracked over several hours post-ingestion to determine iAUC (incremental area under the curve) for various biomarkers.
Results
In Study 1, all tested LDCs elicited minimal plasma glucose responses when consumed alone, confirming their low glycemic impact. Study 2 revealed distinct metabolic benefits when LDCs were co-ingested with a meal. Allulose demonstrated the strongest effects, significantly reducing postprandial glucose and insulin levels while notably increasing plasma GLP-1 concentrations. This suggests a potential role for allulose in enhancing incretin-mediated glucose control. 1-Kestose also exhibited significantly lower plasma glucose and insulin iAUC compared to the reference meal alone, indicating improved glycemic regulation without a significant GLP-1 boost. Resistant maltodextrin (RD) primarily impacted satiety.
RD significantly enhanced subjective satiety between 30 and 180 min post-consumption, suggesting its utility in appetite control. These findings underscore that each LDC possesses unique physiological mechanisms, differentially influencing glucose, insulin,
GLP-1, and satiety.
Key Findings
- Allulose significantly reduced postprandial glucose and insulin levels.
- Allulose significantly increased plasma
GLP-1concentrations. - 1-Kestose significantly lowered plasma glucose and insulin
iAUC. - Resistant maltodextrin significantly enhanced subjective satiety between 30 and 180 min post-consumption.
Why It Matters
This research highlights the potential for targeted nutritional strategies using specific low-digestible carbohydrates to improve metabolic health. For individuals managing glycemic control or seeking weight management, incorporating LDCs like allulose could complement existing approaches by enhancing GLP-1 release and reducing postprandial glucose spikes. Resistant maltodextrin offers a dietary tool for increasing satiety, potentially aiding in calorie reduction. This moves beyond general fiber recommendations towards precision nutrition, suggesting that specific LDCs can be chosen based on desired metabolic outcomes. While acute effects are promising, long-term efficacy and optimal dosing protocols require further investigation before widespread clinical translation.
allulose
1-kestose
resistant-maltodextrin
low-digestible-carbohydrates
glycemic-control
glp-1